Speakers

Adam Stefanski

Executive Director R&D Clinical Research, Diabetes Product Development

Eli Lilly & Company

Alessandro Pocai

Senior Director, NASH & ImmunoMetabolism, CVM, Retina & Pulmonary Hypertension Discovery

Janssen

Alessia Fornoni

Chief, Katz Family Division of Nephrology & Hypertension

University of Miami

Alex Duncan

Chief Scientific Officer

Walden Biosciences

Aliza Thompson

Deputy Director of the Division of Cardiology & Nephrology

FDA

Andrew King

Chief Scientific Officer

Chinook Therapeutics

Anil Chandraker

Medical Director of Kidney Transplantation

Brigham & Women's Hospital

Carol Moreno Quinn

Vice President, Global Medical Lead

CSL Vifor

Charlotte Jones-Burton

Senior Vice President of Product Development & Strategy

Chinook Therapeutics

Chee Kay Cheung

Consultant Nephrologist

University Hospitals of Leicester NHS Trust

Daniel Oliver

Chief Executive Officer

Rejuvenate Bio

Denis Drygin

Chief Scientific Officer

Regulus Therapeutics

Dominik Steubl

Senior Clinical Program Leader

Boehringer Ingelheim

Dorothee Oberdhan

Director, Patient-Centric Outcomes

Otsuka

Dustin Little

Global Clinical Lead, Renal

AstraZeneca

Edmund Lee

Executive Director, Biology

Regulus Therapeutics

Frederick Beddingfield

Chief Executive Officer

Kira Pharmaceuticals

Gabriela Alperovich

Clinical Development Director Nephrology

CSL Vifor

Haresh Selvaskandan

Kidney Research UK Clinical Research Fellow

University of Leicester

Hermann Haller

President

MDI Biological Laboratory

Hiddo Heerspink

Professor

University of Groningen

Holly Bode

Vice President, Government Affairs

American Kidney Fund

Jennifer Schaub

Assistant Professor

University of Michigan

Jerome Rossert

Vice President, Head of Clinical Renal

AstraZeneca

Jochen Reiser

The Ralph C Brown MD Professor & Chairman of Medicine

Rush University

Jonathan Barratt

The Mayer Professor of Renal Medicine

University of Leicester

Josh Tarnoff

Chief Executive Officer

NephCure

Karin Conde-Knape

Senior Vice President Global Drug Discovery

Novo Nordisk

Kerry Cooper

Senior Vice President, Medical Affairs

Prokidney

Kevin Chung

Chief Medical Officer

SeaStar Medical

Kirk Campbell

Professor of Medicine

Icahn School of Medicine at Mount Sinai

Kirtida Mistry

Pediatric Nephrologist, Division of Cardiology & Nephrology

FDA

Maarten Kraan

Chief Medical Officer

AM-Pharma

Manish Maski

Head, Global Rare Nephrology Medical Affairs

Sanofi

Marjia Chiara Magnone

Vice President Kidney Diseases & Boston Site Head

Janssen

Mathijs Bunck

Associate Vice President

Eli Lilly & Company

Matthew Breyer

Distinguished Scientist

Johnson & Johnson

Matthias Kretzler

Professor of Internal Medicine & Bioinformatics

University of Michigan

Michael Hansen

Head of Biomarkers for Chronic Kidney Disease & Acute Kidney Injury

Janssen

Michael Spigler

Vice President, Patient Support & Education

American Kidney Fund

Natalie Skrypnyk

Scientist

Janssen

Nicholas Medjeral-Thomas

Clinical Research Fellow

Imperial College London

Pernille Laerkegaard Hansen

Executive Director, Head of Bioscience Renal

AstraZeneca

Peter Boor

Chair of Translational Nephropathology

RWTH Aachen

Peter Heerma

Chief Commercial Officer

Travere Therapeutics

Radko Komers

Executive Director, Global Lead of Clinical Development Nephrology

Travere Therapeutics

Richard Leigh-Pemberton

Vice President, Clinical Development

Q32 Bio

Richard Nkulikiyinka

Vice President, Head of Therapeutic Area Cardiology & Nephrology

Bayer

Roberta Weiss

Senior Director, Global Clinical Lead

Pfizer

Sean Barbour

Clinical Associate Professor

University of British Columbia

Shalabh Gupta

President & Chief Executive Officer

Unicycive Therapeutics

Shaun Flint

Clinical Development, Nephrology

CSL Vifor

Sibylle Hauske

Senior Director, Clinical Development, Chronic Kidney Disease

Boehringer Ingelheim

Stefan Wawersik

Vice President, Research

Q32 Bio

Thomas Miller

Senior Vice President

Walden Biosciences

Thomas Natoli

Director of Pharmacology, Cardiovascular & Metabolic Disease

Janssen

Tom Frohlich

CHief Operating Officer

Chinook Therapeutics

Uptal Patel

Head of Early Clinical Renal, CVRM

AstraZeneca